Brevan Howard Capital Management LP Intellia Therapeutics, Inc. Transaction History

Brevan Howard Capital Management LP

  • $11 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$60.88 - $161.91 $2.24 Million - $5.96 Million
-36,788 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$46.59 - $83.68 $988,732 - $1.78 Million
-21,222 Reduced 36.58%
36,788 $2.95 Million
Q4 2020

Feb 12, 2021
BUY
$18.83 - $63.53 $1.09 Million - $3.69 Million
58,010 New
58,010 $3.16 Million

Others Institutions Holding NTLA

# of Institutions
326
Shares Held
88.8M
Call Options Held
673K
Put Options Held
865K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.56B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email